Fluoxetine in KCNC1-related Disorder

NCT06341127 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

1

Enrollment

OTHER

Sponsor class

Conditions

KCNC1 Related Disorder
Genetic Disease
Rare Diseases

Interventions

DRUG: Fluoxetine

Sponsor

Holland Bloorview Kids Rehabilitation Hospital

Collaborators

[object Object]